Forward Pharma A S

Company Profile

Forward Pharma A S had its IPO on 2014-10-15 under the ticker symbol FWP.

The company operates in the Healthcare sector and Biotechnology & Medical Research industry. Forward Pharma A S has a staff strength of 4 employees.

Stock update

Shares of Forward Pharma A S opened at $2.56 at the start of the last trading session i.e. 2023-03-19.

The stocks traded within a range of $2.56 - $2.56, and closed at $2.56.

This is a 0% increase from the previous day's closing price.

A total volume of 0 shares were traded at the close of the day’s session.

In the last one week, shares of Forward Pharma A S have slipped by -1.54%.

Forward Pharma A S's Key Ratios

Forward Pharma A S has a market cap of $13.83 million, indicating a price to book ratio of 0.3107 and a price to sales ratio of 0.

In the last 12-months Forward Pharma A S’s revenue was $0 with a gross profit of $0 and an EBITDA of $-3385000. The EBITDA ratio measures Forward Pharma A S's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Forward Pharma A S’s operating margin was 0% while its return on assets stood at -3.42% with a return of equity of -0.83%.

In Q2, Forward Pharma A S’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Forward Pharma A S’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

0.13

Its diluted EPS in the last 12-months stands at $-0.271 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0.13. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Forward Pharma A S’s profitability.

Forward Pharma A S stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 16.959. Its price to sales ratio in the trailing 12-months stood at 0.

Forward Pharma A S stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$65.64 million

Total Liabilities

$3.56 million

Operating Cash Flow

$-92000.00

Capital Expenditure

$0

Dividend Payout Ratio

0%

Forward Pharma A S ended 2023 with $65.64 million in total assets and $0 in total liabilities. Its intangible assets were valued at $65.64 million while shareholder equity stood at $62.08 million.

Forward Pharma A S ended 2023 with $0 in deferred long-term liabilities, $3.56 million in other current liabilities, 158000.00 in common stock, $-16422000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $65.28 million and cash and short-term investments were $65.28 million. The company’s total short-term debt was $0 while long-term debt stood at $0.

Forward Pharma A S’s total current assets stands at $65.64 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $138000.00 compared to accounts payable of $80000.00 and inventory worth $0.

In 2023, Forward Pharma A S's operating cash flow was $-92000.00 while its capital expenditure stood at $0.

Comparatively, Forward Pharma A S paid $0 in dividends in 2023.

Other key metrics

Current Trading Price

$2.56

52-Week High

$6.16

52-Week Low

$1.43

Analyst Target Price

$

Forward Pharma A S stock is currently trading at $2.56 per share. It touched a 52-week high of $6.16 and a 52-week low of $6.16. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $2.51 and 200-day moving average was $3.46 The short ratio stood at 1.78 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 1290.4% are held by institutions.